2026 PharmaTech & Clinical Trials Innovation Award Now Open

Revolutionizing Drug Discovery and Development with Technology

The 2026 PharmaTech & Clinical Trials Innovation Award is now open for entries. This award recognizes technologies transforming pharmaceutical research, clinical trials, and drug development by improving trial design, recruitment, monitoring, compliance, and operational efficiency across the research lifecycle.

What This Award Recognizes

The PharmaTech & Clinical Trials Innovation Award honors solutions that help modernize how therapies are discovered, tested, and advanced toward real-world use. Eligible entries may include trial operations platforms, recruitment and retention tools, decentralized trial technologies, AI-driven drug development tools, data infrastructure, compliance solutions, and other innovations that improve speed, quality, access, or execution in pharmaceutical research and clinical trials.

Entry Schedule

• Entries Open: June 30, 2026
• Early Bird Deadline: July 24, 2026
• Final Entry Deadline: August 28, 2026
• Winners Announced: September 4, 2026

Why Apply

Winning a HealthTechNode award can help validate your work, strengthen credibility with sponsors, research organizations, partners, and investors, and increase visibility across the health technology landscape. If your solution is helping improve clinical research, streamline development, or expand patient access to trials, this is an opportunity to earn recognition for that impact.